Company

PRESSURE Consortium

Research Services Key Challenges That Preclude the Effective Treatment of Eac: a Consensus Treatment in the Eu Based on Real-world Efficacy Data Is Lacking. Establishing Such Data and Unified Treatment Will Avoid the Detrimental Effects of Some Therapies. Likewise 126 employees

Employees: 126

pressurenetwork.eu LinkedIn

PRESSURE Consortium Overview

Headquarters: Key Challenges That Preclude the Effective Treatment of Eac: a Consensus Treatment in the Eu Based on Real-world Efficacy Data Is Lacking. Establishing Such Data and Unified Treatment Will Avoid the Detrimental Effects of Some Therapies. Likewise
Website: pressurenetwork.eu
Industry: Research Services
Employees: 126
NAICS: Scientific Research and Development Services

Research and Development in the Physical, Engineering, and Life Sciences

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Keywords

About PRESSURE Consortium

An MSCA-Doctorate Network that aims to improve the outcome of esophageal cancer. The PRESSURE consortium brings together expert groups from the Netherlands, Germany, Italy, Sweden, Czech Republic, France, and Denmark, to address key challenges that preclude the effective treatment of EAC: A consensus treatment in the EU based on real-world efficacy data is lacking. Establishing such data and unified treatment will avoid the detrimental effects of some therapies. Likewise, the current fragmentation of expertise and tools across Europe prevents an effective development of new approaches. PRESSURE members have independently amassed a wealth of samples, disease models, clinical data, scientific know-how, and cutting-edge technologies. In the consortium, these elements will be joined to develop novel and optimized treatment strategies and diagnostics.